| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-05-0283 |
| P698 | PubMed publication ID | 16243812 |
| P50 | author | Walter Kolch | Q30504262 |
| Fahd Al-mulla | Q42623473 | ||
| P2093 | author name string | Suzanne Hagan | |
| Elizabeth Mallon | |||
| Karin Oien | |||
| Barry Gusterson | |||
| Jorge J Curto García | |||
| Rhona Ferrier | |||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| cancer metastasis | Q120912394 | ||
| P304 | page(s) | 7392-7397 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis | |
| P478 | volume | 11 |
| Q57498216 | A New Linkage between the Tumor Suppressor RKIP and Autophagy: Targeted Therapeutics |
| Q28478945 | A new model for raf kinase inhibitory protein induced chemotherapeutic resistance |
| Q36945927 | A new p53 target gene, RKIP, is essential for DNA damage-induced cellular senescence and suppression of ERK activation |
| Q34212421 | A novel model to combine clinical and pathway-based transcriptomic information for the prognosis prediction of breast cancer |
| Q38321663 | Aberrant methylation and loss expression of RKIP is associated with tumor progression and poor prognosis in gastric cardia adenocarcinoma |
| Q44030219 | Additive effect on survival of Raf kinase inhibitor protein and signal transducer and activator of transcription 3 in high-grade glioma |
| Q39192269 | BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells |
| Q41848152 | Biology using engineering tools: the negative feedback amplifier |
| Q34979672 | Cilia movement regulates expression of the Raf-1 kinase inhibitor protein |
| Q55317101 | Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors. |
| Q37278408 | Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer |
| Q35944617 | Clinicopathological features and prognostic implications of Raf kinase inhibitor protein downregulation in tongue squamous cell carcinoma |
| Q92192957 | Combinatorial Electrophoresis and Mass Spectrometry-Based Proteomics in Breast Milk for Breast Cancer Biomarker Discovery |
| Q38303772 | Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma |
| Q88657525 | Comparative two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) of human milk to identify dysregulated proteins in breast cancer |
| Q34371446 | Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer. |
| Q39259132 | Decreased expression and aberrant methylation of Raf kinase inhibitory protein gene in esophageal squamous cell carcinoma |
| Q39651641 | Development and evaluation of monoclonal antibodies against phosphatidylethanolamine binding protein 1 in pancreatic cancer patients |
| Q37683039 | Dihydroartemisinin induces apoptosis of cervical cancer cells via upregulation of RKIP and downregulation of bcl-2 |
| Q34146377 | Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas |
| Q37799001 | Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry |
| Q39384962 | Effects of BTG2 on proliferation inhibition and anti-invasion in human lung cancer cells |
| Q38756588 | Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study |
| Q38496621 | Expression and significance of RKIP and E-cadherin in lung squamous cell carcinoma |
| Q39125495 | Expression and significance of miRNA-21 and BTG2 in lung cancer |
| Q53397885 | Expression of Raf-1 kinase inhibitory protein in carcinoma of the ampulla of Vater. |
| Q33937454 | Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival. |
| Q39386021 | Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia |
| Q34449946 | Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that regulate epithelial-mesenchymal transition |
| Q58183271 | Gene expression in early stage cervical cancer |
| Q38480261 | Gene set enrichment analysis of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma. |
| Q34351457 | Genetic variants in RKIP are associated with clear cell renal cell carcinoma risk in a Chinese population |
| Q36896127 | Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer. |
| Q40224274 | Identification and characterization of PEBP as a calpain substrate |
| Q37103526 | Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell lines |
| Q36116223 | Identification of novel metastasis suppressor signaling pathways for breast cancer |
| Q54581866 | Immunohistochemical detection of Raf kinase inhibitor protein in normal cervical tissue and cervical cancer tissue. |
| Q51765725 | Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue. |
| Q39820496 | Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction |
| Q38900752 | Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance |
| Q30435922 | Learning therapeutic lessons from metastasis suppressor proteins |
| Q34257278 | Ligand binding study of human PEBP1/RKIP: interaction with nucleotides and Raf-1 peptides evidenced by NMR and mass spectrometry |
| Q47145939 | LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression |
| Q48028205 | Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations. |
| Q63405991 | Loss of RKIP expression is associated with poor survival in GISTs |
| Q37001604 | Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer |
| Q37501848 | Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC) |
| Q54632531 | Loss of Raf-1 kinase inhibitory protein in pancreatic ductal adenocarcinoma |
| Q54647868 | Loss of Raf‐1 kinase inhibitor protein expression is associated with lymph node metastasis in papillary thyroid cancer |
| Q54446025 | Low RKIP expression associates with poor prognosis in bladder cancer patients. |
| Q42974463 | MAP kinase meets mitosis: a role for Raf Kinase Inhibitory Protein in spindle checkpoint regulation |
| Q31143480 | Mapping the interactome of overexpressed RAF kinase inhibitor protein in a gastric cancer cell line |
| Q28394526 | Metastasis suppressor genes at the interface between the environment and tumor cell growth |
| Q35981102 | Metastasis suppressors and their roles in breast carcinoma |
| Q37869335 | Metastasis-suppressor genes in clinical practice: lost in translation? |
| Q38945186 | MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer |
| Q37702055 | Molecular mechanism of hepatitis B virus (HBV) on suppression of raf kinase inhibitor protein (RKIP) expression |
| Q26782525 | Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics |
| Q39286167 | Overexpression of RKIP and its cross-talk with several regulatory gene products in multiple myeloma |
| Q36452213 | Phosphatidylenthanolamine Binding Protein aka Raf Kinase Inhibitor Protein: A Brief History of Its Discovery and the Remarkable Diversity of Biological Functions |
| Q39054965 | Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation |
| Q40005196 | Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma. |
| Q85743861 | Positive effect of high RKIP expression on reduced distant metastasis by chemotherapy when combined with radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a prospective study |
| Q51345281 | Pranlukast, a novel binding ligand of human Raf1 kinase inhibitory protein. |
| Q35956840 | Prognostic value of RKIP and p-ERK in gastric cancer |
| Q82602665 | Prognostic value of raf kinase inhibitor protein in esophageal squamous cell carcinoma |
| Q42290621 | Promoter methylation and expression of Raf kinase inhibitory protein in esophageal squamous cell carcinoma |
| Q43832494 | Prospective study of prognostic value of Raf kinase inhibitory protein and pretreatment plasma Epstein-Barr virus DNA for distant metastasis in locoregionally advanced nasopharyngeal carcinoma. |
| Q34041404 | Proteomic analysis reveals molecular biological details in varioliform gastritis withoutHelicobacter pyloriinfection |
| Q37977415 | Proteomic research progress in lymphatic metastases of cancers |
| Q94363716 | RAF Kinase Inhibitory Protein Expression and Phosphorylation Profiles in Oral Cancers |
| Q44208151 | RAF kinase inhibitory protein (RKIP) modulates cell cycle kinetics and motility |
| Q83770396 | RAF-kinase inhibitor protein (RKIP) downregulation in esophageal cancer and its metastases |
| Q39105315 | RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2. |
| Q49447218 | RKIP and peroxiredoxin 2 expression predicts the proliferative potential of gastric cancer stem cells |
| Q36986264 | RKIP contributes to IFN-γ synthesis by CD8+ T cells after serial TCR triggering in systemic inflammatory response syndrome |
| Q34634649 | RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy |
| Q36629504 | RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration. |
| Q38322277 | RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-κB/Snail/YY1/RKIP resistance-driver loop |
| Q58704356 | RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact |
| Q38077517 | RKIP: much more than Raf kinase inhibitory protein |
| Q24316181 | Raf family kinases: old dogs have learned new tricks |
| Q45722072 | Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes' B colorectal cancer patients |
| Q34259005 | Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. |
| Q26859628 | Raf kinase inhibitory protein (RKIP): functional pleiotropy in the mammalian brain |
| Q37099967 | Raf kinase inhibitory protein function is regulated via a flexible pocket and novel phosphorylation-dependent mechanism |
| Q28567156 | Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint |
| Q24649908 | Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7 |
| Q37124492 | Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor |
| Q54654227 | Raf-1 Kinase Inhibitory Protein Expression in Thyroid Carcinomas |
| Q36998275 | Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity |
| Q50150396 | Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma |
| Q36140818 | Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling |
| Q42282306 | Reduction of Raf Kinase Inhibitor Protein Expression is Associated with Lymph Node Metastasis in Resectable Non-small Cell Lung Cancer |
| Q42910805 | Reduction of Raf kinase inhibitor protein expression by Bcr-Abl contributes to chronic myelogenous leukemia proliferation |
| Q34291318 | Regulation of RKIP function by Helicobacter pylori in gastric cancer |
| Q24336720 | Regulation of human myoblast differentiation by PEBP4 |
| Q36782534 | Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity. |
| Q35127916 | Retracted: Raf Kinase Inhibitor Protein (RKIP) Blocks Signal Transducer and Activator of Transcription 3 (STAT3) Activation in Breast and Prostate Cancer |
| Q35282099 | Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma |
| Q38322290 | Role of Raf kinase inhibitor protein in Helicobacter pylori-mediated signaling in gastric cancer |
| Q35852597 | Role of Raf-kinase inhibitor protein in colorectal cancer and its regulation by hydroxycamptothecine |
| Q37865381 | Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. |
| Q36439970 | Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction |
| Q35591707 | Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer |
| Q47826711 | Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression. |
| Q38297109 | Snail is a repressor of RKIP transcription in metastatic prostate cancer cells |
| Q59329292 | Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors |
| Q39388734 | The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro |
| Q54601137 | The expression of RKIP, RhoGDI, galectin, c-Myc and p53 in gastrointestinal system of Cr(VI)-exposed rats. |
| Q30887007 | The oxazolidinone derivative locostatin induces cytokine appeasement. |
| Q84310691 | The relationship between Bmi-1 and the epithelial-mesenchymal transition in lung squamous cell carcinoma |
| Q36396579 | The role of microRNAs in breast cancer migration, invasion and metastasis |
| Q37837732 | Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways. |
| Q37548937 | Tumor dormancy and metastasis. |
| Q36616513 | Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth |
| Q42165502 | Unique Pattern of Overexpression of Raf-1 Kinase Inhibitory Protein in Its Inactivated Phosphorylated Form in Human Multiple Myeloma |
| Q53288908 | [The expression and significance of RKIP in lung squamous cell carcinoma tissues]. |
| Q35080175 | cis-Acting elements and trans-acting factors in the transcriptional regulation of raf kinase inhibitory protein expression |
| Q64229735 | α-Ketoglutaric Acid-Modified Carbonate Apatite Enhances Cellular Uptake and Cytotoxicity of a Raf- Kinase Inhibitor in Breast Cancer Cells through Inhibition of MAPK and PI-3 Kinase Pathways |
Search more.